story of the week
Cardiovascular Risk Reduction With Icosapent Ethyl for Hypertriglyceridemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiovascular Risk Reduction With Icosapent Ethyl for Hypertriglyceridemia
N. Engl. J. Med 2018 Nov 10;[EPub Ahead of Print], DL Bhatt, PG Steg, M Miller, EA Brinton, TA Jacobson, SB Ketchum, RT Doyle, RA Juliano, L Jiao, C Granowitz, JC Tardif, CM BallantyneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.